Virginia Tech fraternity Alpha Tau Omega Theta Delta chapter has selected Cycling4aCure as its official philanthropy.
Researchers have identified promising compounds to inhibit a key driver of many forms of the disease, including lung, prostate, colon, bladder and pancreatic cancer.
The Department of Defense has awarded a $1 million grant to Virginia Commonwealth University researchers to test the use of vitamin C in preventing hemorrhagic shock-induced death.
The main threats to local air quality across the United States (as well as most everywhere else) remain smog and particulate pollution, which combined or acting alone trigger millions of hospital visits and health complications for citizens every year.
Virginia Commonwealth University Medical Center has been designated as a Lung Cancer Screening Center by the American College of Radiology, becoming one of the first in the state to earn the designation.
Many of the sunscreens on the market do not provide enough protection from the sun’s damaging rays. Also, some of them contain chemicals that can also cause health problems in their own right.
We welcome the Environmental Protection Agency’s proposal to limit carbon pollution from power plants.
Starting May 19, UVA Multi-Specialty Clinic in Augusta will change its name to UVA Specialty Care Pinnacle Drive and begin caring for patients at 9 Pinnacle Dr., Suite A03 in Fishersville.
A new clinical trial at Virginia Commonwealth University is studying the safety and effectiveness of a new device for patients diagnosed with moderate to severe heart failure.
The two species of bacteria are genetically similar – both contagious, both drug resistant, both preying upon people with cystic fibrosis or weakened immune systems – yet they go about their sinister work very differently.
Not surprisingly, there are thousands of green apps out there that make it easier for people to find and share information to help us all become better stewards of the natural environment.
Groundbreaking research at the University of Virginia School of Medicine that aims to dramatically increase the number of lungs that can be used for transplant has received a $3.3 million grant from the National Institutes of Health. The work seeks to use a drug developed at UVA to rehabilitate lungs that are currently deemed unusable.